Margareta Spjut
@Healthinvest Partners Ab
Latest period2024 - Q3ReportedManaged Assets$212.751MTotal holdings36
Assets growth rate29.73%Assets growth rate (2-Q avg)14.76%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Healthinvest Partners Ab's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.
Assets under management
The assets under management (AUM) of Healthinvest Partners Ab over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 212.751M in assets, with a quarterly growth rate of 29.73% and a 2-quarter average growth rate of 14.76%. The portfolio is managed by Margareta Spjut, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
REGNRegeneron Pharmaceuticals
| 3.48% | $7.388M 7,028 shares@ $1051.25 avg price | Increased 1.96% |
NBIXNeurocrine Biosciences Inc
| 3.29% | $6.983M 60,607 shares@ $115.23 avg price | Increased 156.49% |
ALKSAlkermes Plc
| 3.12% | $6.623M 236,610 shares@ $28.0 avg price | Increased 243.91% |
ITCIIntra-cellular Therapies Inc
| 2.91% | $6.189M 84,578 shares@ $73.17 avg price | Increased 135.99% |
HRMYHarmony Biosciences Hldgs In
| 2.86% | $6.075M 151,875 shares@ $40.0 avg price | Increased 335.18% |
UFPTUfp Technologies Inc
| 2.69% | $5.716M 18,048 shares@ $316.71 avg price | Increased 84.17% |
MIRMMirum Pharmaceuticals Inc
| 2.54% | $5.395M 138,321 shares@ $39.0 avg price | Increased 83.94% |
DXCMDexcom Inc
| 1.7% | $3.604M 53,757 shares@ $67.04 avg price | Increased 55.9% |
ACLXArcellx Inc
| 1.58% | $3.36M 40,230 shares@ $83.51 avg price | Increased 78.84% |
IONSIonis Pharmaceuticals Inc
| 1.56% | $3.313M 82,691 shares@ $40.06 avg price | Increased 103.22% |